Iradimed Corp. (IRMD) Tops Q2 EPS by 5c, beats revenue

Iradimed Corp. (NASDAQ: IRMD) reported Q2 EPS of $0.36, $0.05 better than the analyst estimate of $0.31. Revenue for the quarter came in at $16.13 million versus the consensus estimate of $15.66 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Morgan Stanley Starts OGE Energy (OGE) at Equalweight
• MSCI acquires First Street for $120M to expand climate risk data